Texas has reached an $84 million settlement with a prescription drug maker convicted of inflating drug prices to the Medicaid program.
The agreement averts lengthy appeals after a Travis County jury verdict in February. Actavis Inc. inaccurately reported their prices, according to attorneys. This lead Medicaid to overpay pharmacies. CEO Doug Boothe vows that the New Jersey company will continue to report prices legally and under the terms of the agreement.